Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Original Research

Accepted on 14 Jan 2025

Model-guided Development of Pharmacokinetic/Pharmacody-2 namic Cut-offs and Evaluation of Sitafloxacin Dosing Regi-3 mens against Target Pathogens 4

in Pharmacology of Infectious Diseases

Hailan Wu
Yi Li
Xin Li
Yaxin Fan
Beining Guo
Xiaofen Liu
Wanzhen Li
Mengting Chen
Yan Chen
Jing Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1476158

Original Research

Published on 09 Jan 2025

Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients

in Pharmacology of Infectious Diseases

Jing Wang
Qiu Fang
Xuemei Luo
Lu Jin
Huaijun Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1524272

146 views

Editorial

Published on 06 Jan 2025

Editorial: Novel pharmacological targets and strategies to treat neglected global diseases (NGDs): an LMIC perspective

in Pharmacology of Infectious Diseases

Kishor M. Wasan
Somia Iqtadar
Celestin Nzanzu Mudogo
Miguel Angel Chávez-Fumagalli

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1527705

465 views

Systematic Review

Accepted on 03 Jan 2025

Efficacy and Safety of Tenofovir and Entecavir in Patients with Chronic Hepatitis B-Related Cirrhosis: A Systematic Review and Meta-analysis

in Pharmacology of Infectious Diseases

Lu Cao
Li Li
Lixing Yang
Nan Zhou
Yu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1507117

104 views

Original Research

Published on 03 Jan 2025

The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model

in Pharmacology of Infectious Diseases

Changjing Xu
Junlong Zhu
Kun Tu
Hui Tang
Xinxin Zhou
Qiuyu Li
Kun Chen
Xuping Yang
Yilan Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1505653

160 views

Original Research

Published on 03 Jan 2025

Efficacy, safety, and therapeutic drug monitoring of polymyxin B sulfate and colistin sulfate in critically ill patients: a real-world retrospective study

in Pharmacology of Infectious Diseases

Yijing Zhang
Chuhui Wang
Jiaojiao Chen
Chuqi Bai
Dan Sun
Yulan Qiu
Mengmeng Teng
Yalin Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466888

172 views

Brief Research Report

Accepted on 27 Dec 2024

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients

in Pharmacology of Infectious Diseases

Salvador Resino
Ana Virseda-Berdices
Oscar Brochado-Kith
Juan Berenguer
Juan González-García
Leire Pérez-Latorre
Carmen Busca Arenzana
Cristina Díez
Rafael Micán
Amanda Fernández-Rodríguez

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1436198

Review

Published on 19 Dec 2024

Clade Ib: a new emerging threat in the Mpox outbreak

in Pharmacology of Infectious Diseases

Shriyansh Srivastava
Laxmi
Khyati Sharma
Sathvik Belagodu Sridhar
Sirajunisa Talath
Javedh Shareef
Rachana Mehta
Prakisini Satapathy
Ranjit Sah

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1504154

865 views

Systematic Review

Published on 19 Dec 2024

Effectiveness and safety of echinocandins combination therapy with the standard of care compared to the standard of care monotherapy for the treatment of invasive aspergillosis infection: a meta-analysis

in Pharmacology of Infectious Diseases

Yazed Saleh Alsowaida
Bader Alshoumr
Shuroug A. Alowais
Khalid Bin Saleh
Alia Alshammari
Kareemah Alshurtan
Haytham A. Wali

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1500529

496 views

Original Research

Published on 18 Dec 2024

Proteomic study of the inhibitory effects of tannic acid on MRSA biofilm

in Pharmacology of Infectious Diseases

Yang Miao
Wang Shuang
Qu Qianwei
Liu Xin
Peng Wei
Yang Hai
Zhou Yonghui
Yu Xinbo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413669

479 views

Original Research

Published on 13 Dec 2024

Alhagi maurorum extract in combination with lytic phage cocktails: a promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis

in Pharmacology of Infectious Diseases

Arezoo Mirzaei
Bahram Nasr Esfahani
Mustafa Ghanadian
Jeroen Wagemans
Rob Lavigne
Sharareh Moghim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1483055

681 views

Original Research

Published on 12 Dec 2024

Which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment: evidence from FDA Adverse Event Reporting System database from 2013 to 2024

in Pharmacology of Infectious Diseases

Sheng Wei
Changping He
Xiangping Xie
Anping Zhang
Simin Tang
Sha Li
Yanlang He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491921

846 views

Original Research

Published on 12 Dec 2024

Factors influencing vancomycin trough concentration in burn patients: a single center retrospective study

in Pharmacology of Infectious Diseases

Yan Shi
Zongqi Yin
Qin Zhang
Lei Yi
Yi Dou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377930

279 views

Editorial

Published on 11 Dec 2024

Editorial: Peptides against infectious diseases: from antimicrobial peptides to vaccines

in Pharmacology of Infectious Diseases

Joanna Bojarska
Xiumin Wang
Mariusz Skwarczynski

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1522148

467 views

Review

Published on 06 Dec 2024

Voriconazole: a review of adjustment programs guided by therapeutic drug monitoring

in Pharmacology of Infectious Diseases

Li Jiang
Zhiqiang Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439586

454 views

Original Research

Published on 05 Dec 2024

Impact on parasitemia, survival time and pro-inflammatory immune response in mice infected with Plasmodium berghei treated with Eleutherine plicata

in Pharmacology of Infectious Diseases

Antônio Rafael Quadros Gomes
Ana Laura Gadelha Castro
Gleison Gonçalves Ferreira
Heliton Patrick Cordovil Brígido
Everton Luiz Pompeu Varela
Valdicley Vieira Vale
Liliane Almeida Carneiro
Maria Fâni Dolabela
Sandro Percario

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1484934

438 views

Navigation group

Articles

Model-guided Development of Pharmacokinetic/Pharmacody-2 namic Cut-offs and Evaluation of Sitafloxacin Dosing Regi-3 mens against Target Pathogens 4

Population pharmacokinetics and dosing optimization of imipenem in Chinese elderly patients

Editorial: Novel pharmacological targets and strategies to treat neglected global diseases (NGDs): an LMIC perspective

Efficacy and Safety of Tenofovir and Entecavir in Patients with Chronic Hepatitis B-Related Cirrhosis: A Systematic Review and Meta-analysis

The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model

Efficacy, safety, and therapeutic drug monitoring of polymyxin B sulfate and colistin sulfate in critically ill patients: a real-world retrospective study

PBMCs gene expression predicts liver fibrosis regression after successful HCV therapy in HIV/HCV-coinfected patients

Clade Ib: a new emerging threat in the Mpox outbreak

Effectiveness and safety of echinocandins combination therapy with the standard of care compared to the standard of care monotherapy for the treatment of invasive aspergillosis infection: a meta-analysis

Proteomic study of the inhibitory effects of tannic acid on MRSA biofilm

Alhagi maurorum extract in combination with lytic phage cocktails: a promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis

Which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment: evidence from FDA Adverse Event Reporting System database from 2013 to 2024

Factors influencing vancomycin trough concentration in burn patients: a single center retrospective study

Editorial: Peptides against infectious diseases: from antimicrobial peptides to vaccines

Voriconazole: a review of adjustment programs guided by therapeutic drug monitoring

Impact on parasitemia, survival time and pro-inflammatory immune response in mice infected with Plasmodium berghei treated with Eleutherine plicata